Not yet recruiting NCT07720102
Patient Reported Outcomes Following Percutaneous Lung Ablation
For patients and families
In plain language
An automatic summary of structured registry data. It is an orientation aid, not a substitute for the official protocol or a physician assessment.
- What is being studied
- The protocol lists: Non-Interventional Study.
- Who it may be relevant to
- Registry conditions: Lung Neoplasm. Basic parameters: from 18 years · All.
- What needs checking
- Age, condition and sex are only basic indicators. Prior treatment, laboratory values and other mandatory requirements appear in the eligibility criteria below.
- Where it takes place
- United States
- Next step
- Save the trial, show it to the treating physician, and confirm current recruitment with the study center. Costs, documents and travel →
Unsure about the terms? Read our patient guide →
Overview
This study evaluates satisfaction with percutaneous ablation and any symptoms experienced before and after the procedure in patients with lung tumors.
Interventions
- Other Non-Interventional Study
Non-interventional study
Primary outcome measures
- Symptom severity following percutaneous lung ablation [Time frame: Baseline (prior to ablation), 1 day, 3 days, 7 days, 1 month, 3 months]
Eligibility criteria
Inclusion criteria
- Undergoing percutaneous lung ablation
Exclusion criteria
- Decline to participate in research
Criteria are shown verbatim from the registry (in English). Final eligibility is always assessed by the study center.
Healthy volunteers: No
Study design
- Observational model
- Cohort
Study locations
United States · 1 center
- Mayo Clinic in Rochester — Rochester
Identifiers
NCT: NCT07720102 · 26-000294